Micronoma to Provide Oncobiota Solution and Company Updates During JPM Life Science Conference Week 2023
SAN DIEGO--(BUSINESS WIRE)--Micronoma, the first biotech company offering early cancer detection using a microbiome-driven liquid biopsy platform, today announced that Sandrine Miller-Montgomery, Ph.D., Pharm.D., CEO and Co-founder of Micronoma will participate in J.P. Morgan Week in San Francisco, CA in January 2023. Miller-Montgomery will present company updates at the following...
